Table 1. Shows the clinicopathological factors in different groups of the study.
- |
Malignant (HCC)
N (%) |
CHC
(HCV) N (%) |
Healthy Control
N (%) |
P | χ2(a) |
---|---|---|---|---|---|
Age:
≥ 57.8 < 57.8 |
35 (58.3%) 25 (41.7%) |
21 (50%) 21 (50%) |
9 (50%) 9 (50%) |
.657 NS | 0.839 |
Sex:
Male (88) Female (32) |
43 (71.7%) 17 (28.3%) |
33 (78.6%) 9 (21.4%) |
12 (66.7%) 6 (33.3%) |
.582 NS | 1.084 |
Smoking:
Smoker (53) Non-Smoker (67) |
23 (38.3%) 37 (61.7%) |
21 (50%) 21 (50%) |
9 (50%) 9 (50%) |
.437 NS | 1.656 |
HCV-antibodies:
Positive (94) Negative (26) |
52 (86.7%) 8 (13.3%) |
42 (100%) 0 (0%) |
0 (0%) 18 (100%) |
.000** | 79.149 |
HBV-sAg:
Positive(6) Negative(114) |
6 (10%) 54 (90%) |
0 (0%) 42 (100%) |
0 (0%) 18 (100%) |
.043* | 6.316 |
Cirrhosis:
Cirrhotic(70) Non-cirrhotic(50) |
49(81.7%) 11(18.3%) |
9(21.4%) 33(78.6%) |
0(0%) 18(100%) |
.000** | 39.840 |